Form D · Biotechnology

INOVIO PHARMACEUTICALS, INC.

Plymouth Meeting, PA · CIK 0001055726

Offering snapshot reported Jan 24, 2020 · SEC filing

Reported sold
$4.04M
Offering amount: $4.04M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 24, 2020Initial$4,040,590No comparison1SEC filing
Aug 15, 2019Initial$15,164,526No comparison14SEC filing
Sep 18, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-358860
Convertible bonds with an aggregate principal amount of 4.7 billion Korean Won were sold, which is approximately $4 million based on the exchange rate on the date of issuance of the bonds.
Convertible Bonds

Source: Form D, filed Jan 24, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Simon X. Benito Director
Angel Cabrera Director
Morton Collins Director
Laurent Humeau Executive
Peter Kies Executive
J. Jospeh Kim Director, Executive
Ann C. Miller Director
Jacqueline Shea Executive
Jay Shepard Director
David B. Weiner Director
Wendy L. Yarno Director
Lota S. Zoth Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
660 W. Germantown Pike Suite 110
Plymouth Meeting, PA, 19462